Specialist Directory BMS reports positive Phase II data for relapsed multiple myeloma by Beatrice Gray • 3 days ago
Specialist DirectoryAkeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC by Beatrice Gray • 5 days ago
Specialist Directory BMS reports positive Phase II data for relapsed multiple myeloma Beatrice Gray • 3 days ago
Specialist DirectoryBMS reports positive Phase II data for relapsed multiple myeloma by Beatrice Gray • 3 days ago
Specialist DirectoryAkeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC by Beatrice Gray • 5 days ago
Symptom CheckerArlo points to promising Phase II data for swelling disorder drug by Nabila Anuar • Sep 5, 2026